
Flatiron Health Partners with Veeva to Advance Oncology Research
In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical research—has announced a new strategic partnership with Veeva Systems, a globally recognized leader in cloud-based software solutions for the life sciences industry. The collaboration marks a major step forward in the shared mission of both companies to modernize clinical trials by seamlessly integrating research into routine clinical care.
As part of this initiative, Flatiron Health will officially join the Veeva Product Partner Program, a collaborative network designed to foster innovation and ensure seamless integration between partner technologies and Veeva’s suite of software solutions. This partnership is expected to accelerate product development, optimize configurations for real-world use, and create a more unified experience for both clinical research sites and sponsor organizations.
Bridging the Gap Between Clinical Care and Research
At the heart of this partnership lies the integration of Flatiron Clinical Pipe™ with Veeva Electronic Data Capture (EDC), a leading tool used by clinical trial sponsors to manage and collect clinical trial data electronically. Flatiron Clinical Pipe™, a state-of-the-art EHR-to-EDC connector, is designed to automatically extract structured and unstructured data directly from a site’s electronic health record (EHR) system and map it into the corresponding fields of the EDC platform. This eliminates the time-consuming and error-prone process of manual data transcription—a known bottleneck in clinical trial operations.
With this integration, Flatiron Health and Veeva aim to significantly reduce the administrative burden on clinical research coordinators, data managers, and other site staff who often juggle between EHR and EDC systems to duplicate patient information. By automating data transfer, the solution not only improves accuracy but also enhances operational efficiency, accelerates study timelines, and reduces overall trial costs.
“Our collaboration with Veeva strengthens Flatiron’s ecosystem of partners in clinical research, reinforcing our position as an innovator in the use of technology to streamline clinical trials,” said Alex Deyle, General Manager of Clinical Research at Flatiron Health. “Flatiron Clinical Pipe, integrated with Veeva EDC, enables more streamlined data acquisition for clinical trials across a broader set of both research sites and sponsors—ultimately reducing burden, driving operational efficiencies, and accelerating research timelines.”
Streamlined Implementation, Optimized Performance
One of the core advantages of the new partnership is the promise of accelerated deployment and continuous optimization. By aligning on a shared technical roadmap, both companies can ensure that the integration between Flatiron Clinical Pipe™ and Veeva EDC not only meets current customer needs but also anticipates future challenges and regulatory requirements. Flatiron’s participation in the Veeva Product Partner Program enables both companies to collaborate on performance improvements, product enhancements, and user support protocols in a structured and coordinated fashion.
For existing and prospective customers of both companies, this partnership means faster implementation times, greater support throughout onboarding and trial execution, and increased confidence in the robustness of the solution. It also creates a standardized approach to EHR-to-EDC data transfer that could potentially become a new industry benchmark.
Quantifiable Impact on Data Collection Efficiency

The impact of Flatiron Clinical Pipe™ on clinical trial efficiency is already being felt across research organizations. According to findings published in the journal ESMO Real World Data and Digital Oncology, Flatiron Clinical Pipe™ has demonstrated remarkable time savings and accuracy in data handling. In real-world use cases, clinical research staff were able to accurately transfer thousands of data points—representing the completion of hundreds of case report forms (CRFs)—in mere seconds.
The study found that, on average, it took only 37 seconds for a user to launch, complete, and submit a CRF using Flatiron Clinical Pipe™, compared to the traditional data entry process which can often take several minutes per form. This rapid turnaround translates into substantial time savings over the course of a multi-center clinical trial and drastically reduces the manpower required for data entry tasks.
Equally important, the system ensures that data transferred into the EDC platform mirrors the source data exactly as it appears in the EHR. This fidelity minimizes the need for source data verification (SDV)—a critical and Flatiron Health resource-intensive aspect of data quality assurance in clinical trials. By maintaining data integrity from source to submission, Flatiron Clinical Pipe™ supports higher-quality data acquisition and allows study teams to focus on more value-added activities.
A Platform for Long-Term Innovation
Beyond the immediate benefits of automation and efficiency, the partnership between Flatiron Health and Veeva Systems Flatiron Health is also rooted in a vision for long-term strategic collaboration. As life sciences organizations increasingly seek to digitize their research operations, both companies are committed to co-developing solutions that can adapt to changing industry needs, regulatory frameworks, and technological advancements.
Flatiron and Veeva will work together in a dedicated forum to align on future innovations, identify high-priority use cases, and explore advanced capabilities such as real-time data reconciliation, automated query resolution, and AI-driven trial monitoring. This collaborative approach will allow both companies to evolve their platforms in tandem, offering customers a more cohesive and future-proof clinical research infrastructure.
As decentralized clinical trials (DCTs), real-world evidence (RWE), and patient-centric trial models gain traction, the ability to integrate EHR data into research workflows in a scalable, compliant, and user-friendly manner Flatiron Health will become increasingly important. Through this partnership, Flatiron and Veeva are positioning themselves at the forefront of this transformation.
Transforming the Clinical Trial Experience for Sites and Sponsors
Clinical research sites often struggle with the operational complexities of managing clinical trials. From manual documentation to redundant data entry and ever-evolving protocol requirements, research teams are under immense pressure to do more with less. Sponsors, on the other hand, are equally challenged to collect high-quality data quickly, cost-effectively, and in compliance with stringent regulatory standards.
By streamlining data acquisition through seamless EHR-to-EDC connectivity, Flatiron Clinical Pipe™—especially when integrated with Veeva EDC—offers a solution that aligns incentives for both sites and sponsors. Sites gain back valuable Flatiron Health time and resources, while sponsors receive clean, verified data more quickly, enhancing the ability to meet enrollment targets and shorten development timelines.
This alignment is particularly critical in oncology, a therapeutic area where Flatiron has deep expertise and where trial complexity and patient heterogeneity often pose unique operational challenges. The ability to integrate real-world EHR data into structured trial data capture can be a game changer in bringing life-saving therapies to market more efficiently.
As the clinical research landscape continues to evolve, partnerships like the one between Flatiron Health and Veeva Systems will play Flatiron Health a crucial role in shaping the future. The combination of Flatiron’s advanced data integration technology and Veeva’s industry-leading cloud platform represents a compelling step forward in the modernization of clinical trials.
Together, the two companies are setting a new standard for how clinical trial data is captured, verified, and utilized—moving the industry closer to a world where research is truly embedded into everyday care, and where every patient interaction holds the potential to contribute to medical discovery.
With continued collaboration, technological innovation, and a shared commitment to reducing barriers in research, Flatiron and Veeva are not just optimizing clinical trial workflows—they’re redefining what’s possible.